Can I get GLP-1 medications if I'm not diabetic?

Yes, GLP-1 medications are approved for weight management in non-diabetic patients who meet BMI criteria. Wegovy (semaglutide 2.4mg) and Zepbound (tirzepatide) are specifically FDA-approved for chronic weight management regardless of diabetes status. The STEP trials for semaglutide and SURMOUNT trials for tirzepatide included large non-diabetic populations who achieved significant weight loss (15-22% average). You qualify with BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (hypertension, sleep apnea, dyslipidemia, cardiovascular disease). However, insurance coverage for non-diabetic patients is more challenging - many plans only cover GLP-1s for diabetes treatment. Prior authorization often requires extensive documentation of obesity-related health conditions. Medicare specifically excludes weight loss medications from Part D coverage, though some Medicare Advantage plans offer limited coverage. Cash payment is always an option regardless of diabetes status.